Literature DB >> 21193584

Role of arachidonic acid lipoxygenase metabolites in acetylcholine-induced relaxations of mouse arteries.

Kathryn M Gauthier1, Daniel H Goldman, Nitin T Aggarwal, Yuttana Chawengsub, J R Falck, William B Campbell.   

Abstract

Arachidonic acid (AA) metabolites function as EDHFs in arteries of many species. They mediate cyclooxygenase (COX)- and nitric oxide (NO)-independent relaxations to acetylcholine (ACh). However, the role of AA metabolites as relaxing factors in mouse arteries remains incompletely defined. ACh caused concentration-dependent relaxations of the mouse thoracic and abdominal aorta and carotid, femoral, and mesentery arteries (maximal relaxation: 57 ± 4%, 72 ± 4%, 82 ± 3%, 80 ± 3%, and 85 ± 3%, respectively). The NO synthase inhibitor nitro-L-arginine (L-NA; 30 μM) blocked relaxations in the thoracic aorta, and L-NA plus the COX inhibitor indomethacin (10 μM) inhibited relaxations in the abdominal aorta and carotid, femoral, and mesenteric arteries (maximal relaxation: 31 ± 10%, 33 ± 5%, 41 ± 8%, and 73 ± 3%, respectively). In mesenteric arteries, NO- and COX-independent relaxations to ACh were inhibited by the lipoxygenase (LO) inhibitors nordihydroguaiaretic acid (NDGA; 10 μM) and BW-755C (200 μM), the K(+) channel inhibitor apamin (1 μM), and 60 mM KCl and eliminated by endothelium removal. They were not altered by the cytochrome P-450 inhibitor N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide (20 μM) or the epoxyeicosatrienoic acid antagonist 14,15-epoxyeicosa-5(Z)-enoic acid (10 μM). AA relaxations were attenuated by NDGA or apamin and eliminated by 60 mM KCl. Reverse-phase HPLC analysis revealed arterial [(14)C]AA metabolites that comigrated with prostaglandins, trihydroxyeicosatrienoic acids (THETAs), hydroxyepoxyeicosatrienoic acids (HEETAs), and hydroxyeicosatetraenoic acids (HETEs). Epoxyeicosatrienoic acids were not observed. Mass spectrometry confirmed the identity of 6-keto-PGF(1α), PGE(2), 12-HETE, 15-HETE, HEETAs, 11,12,15-THETA, and 11,14,15-THETA. AA metabolism was blocked by NDGA and endothelium removal. 11(R),12(S),15(S)-THETA relaxations (maximal relaxation: 73 ± 3%) were endothelium independent and blocked by 60 mM KCl. Western immunoblot analysis and RT-PCR of the aorta and mesenteric arteries demonstrated protein and mRNA expression of leukocyte-type 12/15-LO. Thus, in mouse resistance arteries, 12/15-LO AA metabolites mediate endothelium-dependent relaxations to ACh and AA.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21193584      PMCID: PMC3064304          DOI: 10.1152/ajpheart.00696.2009

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  56 in total

1.  Inhibition of maxi-K currents in ferret portal vein smooth muscle cells by the antifungal clotrimazole.

Authors:  A R Rittenhouse; C Parker; C Brugnara; K G Morgan; S L Alper
Journal:  Am J Physiol       Date:  1997-07

2.  A human intermediate conductance calcium-activated potassium channel.

Authors:  T M Ishii; C Silvia; B Hirschberg; C T Bond; J P Adelman; J Maylie
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 3.  Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP.

Authors:  R A Cohen; P M Vanhoutte
Journal:  Circulation       Date:  1995-12-01       Impact factor: 29.690

4.  Arachidonic acid- and acetylcholine-induced relaxations of rabbit aorta.

Authors:  S L Pfister; W B Campbell
Journal:  Hypertension       Date:  1992-11       Impact factor: 10.190

5.  K+ is an endothelium-derived hyperpolarizing factor in rat arteries.

Authors:  G Edwards; K A Dora; M J Gardener; C J Garland; A H Weston
Journal:  Nature       Date:  1998-11-19       Impact factor: 49.962

6.  Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.

Authors:  D C Argentieri; D M Ritchie; M P Ferro; T Kirchner; M P Wachter; D W Anderson; M E Rosenthale; R J Capetola
Journal:  J Pharmacol Exp Ther       Date:  1994-12       Impact factor: 4.030

7.  Vasorelaxation by an endothelium-derived metabolite of arachidonic acid.

Authors:  S L Pfister; N Spitzbarth; W Edgemond; W B Campbell
Journal:  Am J Physiol       Date:  1996-03

8.  Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors.

Authors:  W B Campbell; D Gebremedhin; P F Pratt; D R Harder
Journal:  Circ Res       Date:  1996-03       Impact factor: 17.367

9.  Identification of the 11,14,15- and 11,12, 15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta.

Authors:  S L Pfister; N Spitzbarth; K Nithipatikom; W S Edgemond; J R Falck; W B Campbell
Journal:  J Biol Chem       Date:  1998-11-20       Impact factor: 5.157

10.  Bacterial expression, purification and partial characterization of recombinant rabbit reticulocyte 15-lipoxygenase.

Authors:  H Kühn; B J Thiele; A Ostareck-Lederer; H Stender; H Suzuki; T Yoshimoto; S Yamamoto
Journal:  Biochim Biophys Acta       Date:  1993-05-20
View more
  15 in total

Review 1.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

2.  Endothelium-dependent nitric oxide and hyperpolarization-mediated venous relaxation pathways in rat inferior vena cava.

Authors:  Joseph D Raffetto; Peng Yu; Ossama M Reslan; Yin Xia; Raouf A Khalil
Journal:  J Vasc Surg       Date:  2011-12-30       Impact factor: 4.268

Review 3.  Epoxides and soluble epoxide hydrolase in cardiovascular physiology.

Authors:  John D Imig
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

4.  Oxidized fatty acid analysis by charge-switch derivatization, selected reaction monitoring, and accurate mass quantitation.

Authors:  Xinping Liu; Sung Ho Moon; David J Mancuso; Christopher M Jenkins; Shaoping Guan; Harold F Sims; Richard W Gross
Journal:  Anal Biochem       Date:  2013-07-11       Impact factor: 3.365

5.  Mice lacking macrophage 12/15-lipoxygenase are resistant to experimental hypertension.

Authors:  Tamas Kriska; Cody Cepura; Devora Magier; Lawan Siangjong; Kathryn M Gauthier; William B Campbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-03-30       Impact factor: 4.733

Review 6.  Inducible endothelium-derived hyperpolarizing factor: role of the 15-lipoxygenase-EDHF pathway.

Authors:  William B Campbell; Kathryn M Gauthier
Journal:  J Cardiovasc Pharmacol       Date:  2013-03       Impact factor: 3.105

7.  Endothelial 12(S)-HETE vasorelaxation is mediated by thromboxane receptor inhibition in mouse mesenteric arteries.

Authors:  Lawan Siangjong; Kathryn M Gauthier; Sandra L Pfister; Emer M Smyth; William B Campbell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-11-30       Impact factor: 4.733

8.  Effect of human 15-lipoxygenase-1 metabolites on vascular function in mouse mesenteric arteries and hearts.

Authors:  Tamas Kriska; Cody Cepura; Lawan Siangjong; Tina C Wan; John A Auchampach; Aviv Shaish; Dror Haratz; Ganesh Kumar; John R Falck; Kathryn M Gauthier; William B Campbell
Journal:  Prostaglandins Other Lipid Mediat       Date:  2013-07-16       Impact factor: 3.072

9.  Vascular hepoxilin and trioxilins mediate vasorelaxation through TP receptor inhibition in mouse arteries.

Authors:  L Siangjong; D H Goldman; T Kriska; K M Gauthier; E M Smyth; N Puli; G Kumar; J R Falck; W B Campbell
Journal:  Acta Physiol (Oxf)       Date:  2016-01-04       Impact factor: 6.311

10.  Arachidonic acid-induced dilation in human coronary arterioles: convergence of signaling mechanisms on endothelial TRPV4-mediated Ca2+ entry.

Authors:  Xiaodong Zheng; Natalya S Zinkevich; Debebe Gebremedhin; Kathryn M Gauthier; Yoshinori Nishijima; Juan Fang; David A Wilcox; William B Campbell; David D Gutterman; David X Zhang
Journal:  J Am Heart Assoc       Date:  2013-04-25       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.